Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum
焦虑症谱系中逃避、回避和接近的建模和调节机制
基本信息
- 批准号:10362709
- 负责人:
- 金额:$ 20.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-02 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAmbulatory CareAmygdaloid structureAnhedoniaAnimalsAnxietyAreaAversive StimulusBasic ScienceBehaviorClinicalClinical ResearchCognitive TherapyCollaborationsComputer ModelsConflict (Psychology)Coping BehaviorCorpus striatum structureDataDecision MakingDevelopmentDevelopment PlansDiseaseDisease remissionDorsalDropoutEducational workshopEnsureFosteringFrightFunctional Magnetic Resonance ImagingFutureGoalsGrantHumanImpairmentIndividualInstitutionInternationalInterventionKnowledgeLaboratoriesMajor Depressive DisorderMapsMediatingMedicalMental DepressionMental Health ServicesMental disordersMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMethodsModelingMotivationNational Institute of Mental HealthNeurosciencesOutcomeParticipantPatientsPatternPhysiologyPrefrontal CortexPreparationPsychiatryPublicationsReflex actionResearchResearch Domain CriteriaResearch MethodologyResearch PersonnelResearch TrainingRewardsScienceSouth CarolinaStimulusSymptomsTechniquesTestingTrainingTranslational ResearchTreatment outcomeUniversitiesVentral StriatumWorkWritinganxiety spectrum disordersanxiety-related disordersanxiousapproach avoidance behavioravoidance behaviorbasecareercareer developmentclinical practicecopingcosteffective therapyevidence basehands on researchimprovedimproved outcomemultimodalityneural circuitneuroregulationnoninvasive brain stimulationnovelpre-clinicalprecision medicinepreventreduce symptomsrepetitive transcranial magnetic stimulationresponseskillssubstance misusesymposiumtherapy outcometooltranslational applications
项目摘要
PROJECT ABSTRACT
The proposed K23 Mentored Patient-Oriented Research Career Development Award launches a line of work
aiming to comprehensively target mechanisms of avoidance in anxiety and other disorders; and, it provides Dr.
Christopher Sege with skills necessary to becoming a leading clinical researcher. Dr. Sege’s primary clinical
research career goal is to use cutting-edge translational science to improve mental health care by targeting
precise disorder mechanisms. Need for this research is significant and consistent with NIMH priorities and the
RDoC framework. Avoidance is a core target of anxiety and related disorder treatment, but avoidant behaviors
often persist after symptom reduction and keep many from engaging in treatment at all. Novel methods to
target multiple motive drivers of avoidance early in treatment are needed to improve retention and outcome
especially for the 20% of individuals who do not benefit from and 40% who do not complete treatment. Basic
science provides critical clues as to the multiple mechanisms of real-world avoidance that may be indirectly or
inadequately addressed by current treatment techniques. Crucial goals of work proposed here is to determine
how these mechanisms drive clinical behavior and support subsequent work that develops direct intervention
tools. The proposed project uses direct neurostimulation (repetitive transcranial magnetic stimulation; rTMS) in
concert with precise experimental methods to test how specific reactive (escape) and proactive (avoidance)
coping neurocircuits can be modulated to alter downstream fear and approach-avoid decision-making.
Subsequent R-level applications build on this work to determine coping profiles of treatment completers versus
non-completers, and to test how profiles can be more precisely targeted to improve outcomes. A team of
expert mentors (George, Liu, McTeague, Mobbs, Uhde) will use their extensive knowledge in research-based
and clinical neurostimulation, advanced fMRI analysis and research methods, and creation of translational
science-informed treatment adjuvants to support Dr. Sege in his development. Mentorship, hands-on research
tutorials, coursework, seminars/ workshops, and international conference attendance afforded by the K23 will
ensure that Dr. Sege achieves his career goals to: 1) develop expertise in cutting-edge neurostimulation for
research and clinical use, 2) develop expertise in fMRI analysis and research tools for use in concert with
rTMS to more precisely target ecologically-relevant avoidance behavior, and; 3) develop expertise in creating
adjuvants that improve cognitive behavior therapy outcomes through application of translational science. The
proposed K23 will also foster development in areas of publication, grant writing, and inter-departmental
collaboration, all at an institution – the Medical University of South Carolina – which has a strong track record
and commitment to early stage investigators. Proposed K23 activities will prepare Dr. Sege to become a
cutting-edge clinical researcher and a leader in the development of a precision medicine of psychiatry.
项目摘要
拟设立的K23导师患者导向研究职业发展奖推出一系列工作
旨在全面针对焦虑症和其他障碍的避免机制;
克里斯托弗·塞格拥有成为一名领先的临床研究人员所需的技能。塞格医生的初级临床
研究的职业目标是使用尖端的翻译科学通过有针对性地改善精神卫生保健
精确的无序机制。对这项研究的需求是重要的,并与NIMH的优先事项和
RDoC框架。回避是焦虑和相关障碍治疗的核心目标,但回避行为
通常在症状减轻后仍会持续,并使许多人根本不参与治疗。采用新方法
需要在治疗早期针对多种动机的回避,以改善保留率和结果
尤其是没有受益的20%的人和没有完成治疗的40%的人。基本信息
科学提供了关于现实世界逃避的多种机制的关键线索,这些机制可能是间接的或
目前的治疗技术没有充分解决这一问题。这里提出的工作的关键目标是确定
这些机制如何驱动临床行为并支持开发直接干预的后续工作
工具。建议的项目使用直接神经刺激(重复经颅磁刺激;rTMS)在
配合精确的实验方法,测试特定的反应(逃避)和主动(回避)
应对神经回路可以被调节,以改变下游的恐惧和接近-避免决策。
随后的R-Level应用程序建立在这项工作的基础上,以确定完成治疗的患者与
非完成者,并测试如何更准确地针对个人资料来改善结果。一支由
专家导师(乔治、刘、麦克蒂格、莫布斯、乌德)将在基于研究的基础上使用他们丰富的知识
和临床神经刺激,先进的fMRI分析和研究方法,以及创建翻译
科学知情的治疗辅助剂,以支持Sege博士的发展。指导,实践研究
由K23提供的教程、课程作业、研讨会/研讨会和国际会议将
确保Sege博士实现他的职业目标:1)开发尖端神经刺激方面的专业知识
研究和临床应用,2)开发fMRI分析和研究工具方面的专业知识,以便与
RTMS,以更精确地针对与生态相关的回避行为;以及3)发展专门知识,创造
通过应用翻译科学改善认知行为治疗结果的佐剂。这个
拟议的K23还将促进出版、拨款撰写和跨部门领域的发展
合作,都是在一所机构-南卡罗来纳医科大学-有良好的记录
以及对早期调查的承诺。拟议的K23活动将使Sege博士准备成为
尖端临床研究人员和精神病学精准医学发展的领先者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Sege其他文献
Christopher Sege的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher Sege', 18)}}的其他基金
Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum
焦虑症谱系中逃避、回避和接近的建模和调节机制
- 批准号:
10215704 - 财政年份:2021
- 资助金额:
$ 20.9万 - 项目类别:
Modeling and Modulating Mechanisms of Escape, Avoidance, and Approach in the Anxiety Disorder Spectrum
焦虑症谱系中逃避、回避和接近的建模和调节机制
- 批准号:
10576356 - 财政年份:2021
- 资助金额:
$ 20.9万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Studentship
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 20.9万 - 项目类别:














{{item.name}}会员




